Home/Filings/4/0001415889-24-000304
4//SEC Filing

Stanton Matthew 4

Accession 0001415889-24-000304

CIK 0001733294other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 4:35 PM ET

Size

5.5 KB

Accession

0001415889-24-000304

Insider Transaction Report

Form 4
Period: 2024-01-02
Stanton Matthew
CHIEF SCIENTIFIC OFFICER
Transactions
  • Award

    Stock Option (right to buy)

    2024-01-02+160,650160,650 total
    Exercise: $1.86Exp: 2034-01-01Common Stock (160,650 underlying)
Footnotes (1)
  • [F1]The option to purchase 160,650 shares of common stock was granted on January 2, 2024. The shares underlying the option vest over four years, with 25% of the shares vesting on January 2, 2025 and the remaining shares vesting in equal quarterly installments thereafter.

Issuer

Generation Bio Co.

CIK 0001733294

Entity typeother

Related Parties

1
  • filerCIK 0001814198

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:35 PM ET
Size
5.5 KB